Pure Global

"Xiedi" expands the Evarepamycin coronary artery coating stent - Taiwan Registration 5fee14621e9ca462ca7747b28fadc8e6

Access comprehensive regulatory information for "Xiedi" expands the Evarepamycin coronary artery coating stent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 5fee14621e9ca462ca7747b28fadc8e6 and manufactured by CID S.P.A.. The authorized representative in Taiwan is BUDDY MEDICAL CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
5fee14621e9ca462ca7747b28fadc8e6
Registration Details
Taiwan FDA Registration: 5fee14621e9ca462ca7747b28fadc8e6
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Xiedi" expands the Evarepamycin coronary artery coating stent
TW: โ€œๅธŒ่‰พ่ฟชโ€ ๆ“ด็ซ‹ๅฎ‰ไพ่Š™้›ทๅธ•้ปด็ด ๅ† ็‹€ๅ‹•่„ˆๅก—่—ฅๆ”ฏๆžถ
Risk Class 3

Registration Details

5fee14621e9ca462ca7747b28fadc8e6

DHA05603500700

Company Information

Italy

Product Details

Details are as detailed as approved Chinese instructions

E Cardiovascular Medicine Science

E.0001 Cardiovascular stents

Safety monitoring;; import

Dates and Status

Oct 25, 2021

Oct 25, 2026